UFP Technologies, Inc. reported a 4.1% increase in net sales for the first quarter of 2026, reaching $154.2 million compared to $148.1 million in the same period last year. This growth was primarily driven by a 5.9% rise in sales to the medical market, particularly in the Robotic Surgery, Patient Surfaces and Support, and Interventional and Surgical sub-markets. The company's two largest customers, Stryker and Intuitive Surgical SARL, accounted for 24.8% and 22.1% of total sales, respectively, reflecting a slight increase from the previous year.
The company's gross profit for the quarter was $44.4 million, resulting in a gross margin of 28.8%, up from 28.5% in the prior year. However, selling, general, and administrative expenses rose by 12.3% to $21.0 million, attributed to increased headcount, legal expenses, and higher stock compensation costs. As a result, operating income was $23.4 million, slightly up from $23.1 million in the same quarter of 2025. Net income for the period was $17.5 million, or $2.27 per share, compared to $17.2 million, or $2.24 per share, in the prior year.
UFP Technologies has also been active in strategic acquisitions, having completed several in 2025, including Techno Plastics Industries and Universal Plastics & Engineering Company. These acquisitions are expected to enhance the company's capabilities in manufacturing precision components for medical devices. The company has faced challenges, including workforce turnover related to compliance issues at AJR Enterprises, which has impacted productivity. To address this, UFP has focused on recruiting eligible employees to stabilize operations.
In terms of financial health, UFP Technologies reported total assets of $674.7 million as of March 31, 2026, an increase from $655.1 million at the end of 2025. Total liabilities also rose to $235.8 million, up from $231.2 million, primarily due to increased accounts payable and long-term debt. The company had approximately $137.6 million in outstanding borrowings under its credit agreement, with a weighted average interest rate of about 5.0%.
Looking ahead, UFP Technologies anticipates continued growth driven by demand in the medical sector and potential reimbursement of tariff costs following recent legal rulings. The company plans to enhance operational efficiencies and may pursue further acquisitions to support its growth strategy. However, it remains cautious about economic uncertainties that could impact its liquidity and capital resources in the future.
About UFP TECHNOLOGIES INC
UFP Technologies, Inc. designs and manufactures custom engineered solutions primarily for the medical device, aerospace, defense, automotive, and industrial markets. Its core products include medical device components, sterile packaging, automotive interior parts, and aerospace composites. The company leverages advanced materials, engineering expertise, and proprietary technology to serve top OEMs worldwide, emphasizing innovation, quality, and regulatory compliance in highly specialized, niche segments.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.